Breaking News
January 19, 2018 - Warm-up program for children cuts soccer injuries by 50%
January 19, 2018 - ‘You’re Old and You Need Tests’: What We Heard This Week
January 19, 2018 - Egg-preserving hysterectomy raises heart risks later: study
January 19, 2018 - GA-map Dysbiosis Test identifies IBS patients who respond to FODMAP diet, study shows
January 19, 2018 - Study explores mortality and health-related habits in former elite athletes and their brothers
January 19, 2018 - New biodegradable sensors could assist doctors
January 19, 2018 - Modular gene enhancers may be suitable target in treatment of blood cancer
January 18, 2018 - New precision medicine trial for metastatic pancreatic cancer
January 18, 2018 - Shire Receives FDA Breakthrough Therapy Designation for Maribavir, an Investigational Treatment for Cytomegalovirus (CMV) Infection in Transplant Patients
January 18, 2018 - Pre-Existing Patient-Valve Mismatch Trips Up ViV Implant
January 18, 2018 - Adolescents: health risks and solutions
January 18, 2018 - US woman delivers baby from embryo frozen for 24 years
January 18, 2018 - Study identifies new target for treatment of depression
January 18, 2018 - LJI study reveals key player that promotes skin inflammation in atopic dermatitis
January 18, 2018 - Study devises efficient and economical strategy to screen breast and ovarian cancer gene mutations
January 18, 2018 - Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla (AG200-15) for the Prevention of Pregnancy
January 18, 2018 - Gene Therapy for Inherited Retinal Dystrophy Gets FDA Clearance
January 18, 2018 - Researchers identify a new chemical pathway that helps the brain detect sweet, savory and bitter flavors
January 18, 2018 - IBV develops platform that helps companies to diagnose wellbeing of their workforce
January 18, 2018 - Study to test new precision medicine approach for metastatic pancreatic cancer
January 18, 2018 - World’s first vaccine relieves grass pollen allergy symptoms by at least 25%, study shows
January 18, 2018 - FDA Approves New Indication for Gilotrif (afatinib) in EGFR Mutation-Positive NSCLC
January 18, 2018 - Oncologists Dish on Top Issues for 2018
January 18, 2018 - Researchers identify new potential drug target for Huntington’s disease
January 18, 2018 - Metrohm USA welcomes employees to new headquarters in Florida
January 18, 2018 - Human waste remains main source of fecal pollution in the river Danube
January 18, 2018 - Expert discusses how to stay healthy during flu season
January 18, 2018 - New biomaterials-based system improves T-cell production
January 18, 2018 - Novel gene expression analysis technique can accurately and quickly measure RNA
January 18, 2018 - Grandparents Help Shape Kids’ Views on Aging
January 18, 2018 - Absolutely Zero Stent Thrombosis at 5 Years With Bioabsorbable MiStent
January 18, 2018 - Safe Sleep for Babies | VitalSigns
January 18, 2018 - Pfizer to launch own little white pill
January 18, 2018 - Aged garlic extract may help obese people fight against inflammation, study shows
January 18, 2018 - Sex steroid hormone fluctuations may have direct effects on eye physiology and AMD
January 18, 2018 - Patients with monoclonal gammopathy at risk of developing cancer even after 30 years
January 18, 2018 - Researchers reveal potential of multivalent antibodies for HIV prevention, treatment and cure
January 18, 2018 - Dying cancer patients receiving assisted hydration live longer
January 18, 2018 - Potential male birth control pill could be developed from arrow poison
January 18, 2018 - Research reveals cost-effectiveness of whole-population screening for breast, ovarian cancer gene mutations
January 18, 2018 - Genes involved in spinal cord repair of lamprey also present in mammals, study reveals
January 18, 2018 - Researchers unravel key molecular mechanism of autoimmune and inflammatory diseases
January 18, 2018 - The State of the Drug Discovery Nation Unveiled as New Report Provides Vital Insights for the Development of New Medicines
January 18, 2018 - Dutch Study Links Implants to Increased Breast-ALCL Risk
January 18, 2018 - Five addiction experts weigh in on future of opioid crisis. Their forecast: grim
January 18, 2018 - EXD2 enzyme facilitates protein production in mitochondria
January 18, 2018 - Kessler Foundation wins $735,000 grant for training rehabilitation researchers
January 18, 2018 - Researchers find new way to halt growth of breast cancer cells
January 18, 2018 - Cantex Pharmaceuticals, Inc. Announces FDA Orphan Drug Designation Has Been Granted to CX-01 for Treatment of Acute Myeloid Leukemia
January 18, 2018 - Civilians Now Getting Flu-Like Illness Afflicting Troops
January 18, 2018 - Discovery brings stem cell therapy for eye disease closer to the clinic
January 18, 2018 - Guts of surfers more likely to be colonized by antibiotic-resistant bacteria, study reveals
January 18, 2018 - Bacteria linked to periodontitis may play role in onset of cancer
January 18, 2018 - Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnea
January 18, 2018 - Early Menarche, Menopause Tied to Higher CVD Risk
January 18, 2018 - Pioneering new technique could boost understanding of causes of heart disease
January 18, 2018 - New brain imaging techniques show how infants’ brains process ‘touch’
January 18, 2018 - GSK Receives FDA Approval for Expanded Indication for Fluarix Quadrivalent (Influenza Vaccine) for Persons 6 Months and Older
January 18, 2018 - Blood Markers Point to Maladaptive LV Remodeling
January 18, 2018 - Effect of gut bacteria on specific immune cells underlies persistent liver inflammation
January 18, 2018 - Study reveals new diabetes gene in families with rare blood sugar conditions
January 18, 2018 - Fewer Hospitals Closed After Obamacare Expanded Medicaid
January 18, 2018 - At-Home Breath Training Improves Asthma Quality of Life
January 18, 2018 - Obesity can add five weeks of asthma symptoms per year in preschoolers
January 18, 2018 - Neuronal loss is very limited in Alzheimer’s disease, shows new study
January 18, 2018 - A new strategy proposed for drug discovery
January 17, 2018 - Lactation May Lower T2D Risk in Younger Women
January 17, 2018 - New Atopic Dermatitis Yardstick provides practical guidance and management insights
January 17, 2018 - New biodegradable pressure sensor could help monitor serious health conditions
January 17, 2018 - HSS orders Sectra’s 3D pre-operative planning solution for improving patient outcomes
January 17, 2018 - Study identifies six new genes regions associated with diabetes
January 17, 2018 - Women do not receive timely diagnosis for heart disease
January 17, 2018 - AbbVie’s Upadacitinib Shows Positive Results as Monotherapy in Phase 3 Rheumatoid Arthritis Study, Meeting All Primary and Key Secondary Endpoints
January 17, 2018 - Should President Trump’s Physical Include a Cognitive Screen?
January 17, 2018 - Could gene therapy someday eliminate HIV?
January 17, 2018 - Researchers identify new anti-inflammatory drug target
January 17, 2018 - Loxo Oncology Initiates Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Larotrectinib for the Treatment of TRK Fusion Cancers
January 17, 2018 - Trunk Imaging Tied to Higher Nephrectomy Risk
January 17, 2018 - Campaigners incensed at failings in Africa AIDS war
January 17, 2018 - Research opens door to development of new treatment for type 2 diabetes
Mortality Risk Doubles When Breast Ca Patient Has Mental Illness

Mortality Risk Doubles When Breast Ca Patient Has Mental Illness

image_pdfDownload PDFimage_print

Action Points

  • Note that this analysis of a Medicare dataset found that a history of mental illness was associated with a significant increase in all-cause mortality among women with breast cancer.
  • This may largely be driven by later stage at diagnosis, implying that increased efforts to ensure proper screening may partially address the disparity in outcomes.

Elderly women with breast cancer who have severe mental illness have twice the risk of all-cause mortality as their peers without mental illness, and need more screening, surveillance, and coordinated care from primary care providers and specialists, researchers said.

Results from a large retrospective cohort study revealed an adjusted hazard ratio (HR) of 2.19 in breast cancer patients with severe mental illness compared with those without, according to Melissa L. Santorelli, PhD, of Rutgers School of Public Health in Piscataway, New Jersey, and colleagues.

The 5-year cumulative incidence for all-cause mortality in women with severe mental illness was 38.0%, compared with 19.4% in breast cancer patients without mental illness after adjusting for age, income, race, ethnicity, geographic location, and marital status (P<0.001), the study authors reported online in the Journal of Clinical Oncology.

There was also a statistically significant higher rate of all-cause mortality for women with depression (HR 1.39 after adjusting for age, income, race/ethnicity, SEER location, and marital status) and anxiety and depression (adjusted HR 1.26) than for women with no history of mental illness — likely because of late presentation and delayed diagnosis, the researchers said.

“Our descriptive analysis shows that patients with severe mental illness were diagnosed with later-stage breast cancer more frequently compared with patients without mental illness, which suggests that delayed diagnosis might play a role in survival disparities.”

Breast cancer patients with pre-existing severe mental illness may also be at increased risk of an aggressive form of advanced breast cancer, the researchers cautioned. Although a 20% increased hazard for breast cancer-specific death was observed in these patients, the adjusted HR (1.20) was not significant.

The study was conducted using SEER (Surveillance, Epidemiology, and End Results) and Medicare data on 19,028 women diagnosed with stages I to IIIa breast cancer from 2005 to 2007. Although 80% of patients did not have mental illness, 2.6% had a diagnosis of pre-existing bipolar disorder, schizophrenia, or some other psychotic disorder in the 3 years prior to breast cancer diagnosis. In addition, 7.7% of the study population had a diagnosis of depression, 6.0% had been diagnosed with anxiety, and 3.6% had both anxiety and depression.

When compared with women without mental illness, a larger proportion of patients with severe mental illness had:

  • Diagnosis beyond stage I (46.4% versus 40.2%)
  • Tumor larger than 20 mm (37.6% versus 30.3%)
  • Poorly differentiated tumors (28.0% versus 24.0%)
  • One or more positive lymph nodes at the time of initial diagnosis (40.7% versus 33.2%)

Clinicians need to be aware of these increased risks, step up screening efforts, and work collaboratively with other specialists to improve patient care, the researchers emphasized. Breast cancer patients with pre-existing severe mental illness were also more likely to have a lower median income, and were less likely to be married, the study showed.

“Primary care physicians must place an emphasis on early detection among women with severe mental illness to improve the likelihood that guideline-recommended screening mammograms occur,” Santorelli and colleagues wrote. “They also should work closely with psychiatrists and oncologists on the coordination of care for these patients.”

Similarly, oncologists need to make sure that surveillance mammograms are part of follow-up care for women with severe mental illness who are diagnosed with breast cancer, and more research is needed to better understand how mental illness reduces survival and to identify the best coordination of care models to improve patient outcomes.

Although breast cancer mortality has been declining over the past 30 years, it is estimated that in 2017, approximately 40,000 women in the United States will die from the disease. Elderly women have the highest incidence of breast cancer by age, the researchers pointed out.

The negative impact of mental health on mortality is not confined to patients with breast cancer, the team added. For example, an earlier meta-review of the literature showed that patients with severe mental disorders had an up to 150% increased risk of all-cause mortality.

In an accompanying editorial, Alison R. Hwong, MD, PhD, and Christina Mangurian, MD, of the University of California San Francisco, agreed that many questions remain — for example, the role of psychotropic medications in breast cancer morbidity and mortality needs to be better understood as well as how treatment decisions may differ for patients with severe mental illness.

“Future mixed-methods studies should examine patient understanding of and preference for treatment along with quality and outcomes data that compare women with and without severe mental illness.”

Noting that barriers to diagnosis and treatment currently exist for women with mental illness, Hwong and Mangurian warned that preventive care and treatment needs to be integrated into community mental health clinics “or these women will be overlooked.”

“We believe that preventive healthcare services should be delivered where women are already receiving care, especially for patients with severe mental illness who may have cognitive difficulties in accessing care, are marginally housed, and have low income,” the editorial continued. “Mobile mammography administrators could partner with community mental health clinics to deliver care where the patient already is being seen.”

Screening mammograms for this patient population wouldn’t be technically difficult to implement, but time and money will be needed as well as “an institutional commitment to improving overall medical care for people with severe mental illness.”

Limitations of the study, Santorelli et al noted, include the lack of assessment for psychiatric medications as well as the fact that behavioral factors such as alcohol and substance abuse were not evaluated. In addition, the results may not be generalizable to patients other than elderly women with Medicare coverage.

Santorelli reported having no conflicts of interest; several of the study coauthors reported financial relationships with industry.

Hwang and Mangurian reported having no conflicts of interest.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2017-12-26T12:00:00-0500

Tagged with:

About author

Related Articles